Diabetic retinopathy and inflammation: novel therapeutic targets. - Wikidata - wikimedia - TriplyDB

Diabetic retinopathy and inflammation: novel therapeutic targets.

Diabetic retinopathy and inflammation: novel therapeutic targets.

http://www.wikidata.org/entity/Q41012046

about

Diabetic macular edema: it is more than just VEGF Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant Dexamethasone intravitreal implant in the treatment of diabetic macular edema Targeting inflammation in diabetes: Newer therapeutic options Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.Enhanced apoptosis of monocytes from complication-free juvenile-onset diabetes mellitus type 1 may be ameliorated by TNF-α inhibitors Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy.Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms.The Negative Relationship between Bilirubin Level and Diabetic Retinopathy: A Meta-Analysis Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema.CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.Systematic review and meta-analysis of 16 randomized clinical trials of radix astragali and its prescriptions for diabetic retinopathy.An Aqueous Extract of Radix Astragali, Angelica sinensis, and Panax notoginseng Is Effective in Preventing Diabetic Retinopathy.Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy.Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation.Adenosine Deaminase-2-Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p Differential systemic gene expression profile in patients with diabetic macular edema: responders versus nonresponders to standard treatment.Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy.Current epidemiology of diabetic retinopathy and diabetic macular edema.Inflammation and pharmacological treatment in diabetic retinopathy.Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?Efficacy and vitreous levels of topical NSAIDs.Role of endocannabinoids in the progression of diabetic retinopathy.Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina.Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT.Intravitreal autologous plasmin as a therapeutic modality for diffuse diabetic macular edema.Diabetic retinopathy: a global epidemic.Possible involvement of NETosis in inflammatory processes in the eye: Evidence from a small cohort of patients.miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

P2860

Q26745914-2A93CEA9-86BC-4DD4-968B-0995C56B3E86 Q26774344-1CD598DF-D7AF-4C7C-82DF-2836A7396874 Q26775853-41EA8393-9A94-422D-B692-A51FCCA61017 Q26799423-134F6F39-731F-462A-BE64-86B11E7DF4F0 Q26852726-5E3D0186-8DDA-4BA3-975C-8CACB25B0A18 Q27021701-1682F05C-18BA-45CD-B704-9C45869516C3 Q28078199-6010DE80-DE90-4E09-B005-EF2E12C80814 Q33829214-7D933B9B-E5AD-43FB-9778-3EC0E2738C28 Q33905700-4A0EAAE7-18D1-4836-88E8-18AE4E25AB72 Q34011852-6CAAE525-1F0A-4978-8B23-4F9C05333A8E Q34426246-DEBE4107-844D-4925-87BC-8A723073F35D Q35099967-B8329C3A-A275-4C61-954C-BA6CA79B442D Q36049918-03C28C82-2430-4A6A-ABEC-72C9A302EB91 Q36116068-AF237FA2-1FB1-47B7-99FF-850D0BA1378E Q36311077-B6F0AD37-350E-456D-81B6-683057EB3E7F Q36318318-D1208253-1030-4ADB-8EF6-F2C0D76C0316 Q36410404-F53F8A5D-C790-495E-8638-40701E37BE91 Q36468930-99088CE2-4431-4E52-B385-C2A406324F70 Q36705336-3F8818D8-58BE-44E7-AAE8-694385893F46 Q36746311-DE6BD6FD-EBC7-40AC-B241-5A4768782CCD Q36801815-AF0A7A5C-AB28-4687-933A-3B2582431F82 Q36914007-57A82FC8-10B9-4C09-8261-C50904E662B8 Q37501293-77314E4E-9D65-46C2-BD8B-3AD506323F9F Q37634192-9171947C-3A87-46CF-BD54-F074755D2D2A Q37638770-CC39B6BF-2160-47E6-B160-D2845F0AEA43 Q37712937-00D52FEE-B150-41CC-BD8D-E4EEB026B0A5 Q38010064-C920BB0C-1B52-4ED3-A87F-64BFB4D7FAB4 Q38167309-CD5999F7-5477-41C3-AD7D-3899C1975365 Q38365800-E337BF82-DA3C-4246-BFC5-6829ADA173FB Q38546915-1DE91E0E-35A5-4ADE-A4BC-A3CB0549E2C5 Q38588418-9AA349C7-00C0-47E1-A1DA-3003C24AEADC Q38870510-3485A603-06C8-40B1-B2AF-8548122B5262 Q40509325-571EF2BC-EEC3-4145-BAEA-04CD9951DF01 Q40654664-62E077BD-8F93-4EC6-B5BB-08260565B967 Q41049002-2599FA1D-7E71-4477-83FC-D930E86EFE5C Q41931843-B2CE1E8E-5EBA-4ADB-BCC0-CEBE81D3B004 Q42422328-076824D8-5DB6-4527-82D5-72A23A419A65 Q42585582-5F35822D-ECE3-4462-83A1-0C25A31BF5E6 Q47109169-FFAAA9C6-24C7-4F38-BCA0-7C064B726675 Q47993537-E7ED358F-BBD8-4703-A569-BDAF54451154

P2860

Diabetic retinopathy and inflammation: novel therapeutic targets.

http://www.wikidata.org/entity/Q41012046

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Diabetic retinopathy and inflammation: novel therapeutic targets.

@en

type

label

Diabetic retinopathy and inflammation: novel therapeutic targets.

@en

prefLabel

Diabetic retinopathy and inflammation: novel therapeutic targets.

@en

P1433

Q41012046-70D22B51-5550-41E6-990D-E2F1C672CBDC

P1476

Q41012046-89CF62DD-481F-4E1E-BB7C-B00CD42B24BA

P2093

Q41012046-834301E5-1E55-4260-9970-1CB4C6AD49C0

Q41012046-EE68D757-8067-4E5F-83B0-48585B50D256

P2860

Q41012046-04AE1813-02F9-44B9-9879-F2A9AC203D28

Q41012046-0A0E2C84-75DF-4A45-97CA-D6977C076BF5

Q41012046-0D81B140-7572-4E73-94DB-7A58C69EE57E

Q41012046-103CED60-0BC6-43D3-90F4-3CFF9AD0F96D

Q41012046-13300B8F-6D82-4A9F-931E-B499B04BF90E

Q41012046-142901BD-9433-4B0C-8576-D00E5D4CCEB9

Q41012046-19559C26-C327-4CB0-9A09-5CF03C358A54

Q41012046-1A58A535-9F73-4A6D-80F1-06D77D7F13E8

Q41012046-20EF4FC2-CBB5-4343-9467-84E5AFE2D78D

Q41012046-21499C57-2D56-4B33-AC10-855CC4B0CF90

P304

Q41012046-A642A872-0A33-4335-B475-D1458F2F1F27

P31

Q41012046-F6E31CAC-6D9E-42C7-8D07-7A5BA1E2D068

P356

Q41012046-FE6AD94C-DA6D-478A-8FCE-1C6A3C712906

P407

Q41012046-CF7245D1-248D-472A-AD6B-577B4FF5854E

P433

Q41012046-DAF9D8A3-ABBD-41BE-AA97-E6D3B9D57AD7

P478

Q41012046-21BB0F90-5695-49FF-99AC-552BCD2C2543

P50

Q41012046-81B837B6-0351-49F4-BF9F-A91E5F85927B

Q41012046-B537114D-5080-4928-B736-5861E1276704

P577

Q41012046-9DBA04B1-B6E5-4001-9ACE-36579539A722

P698

Q41012046-B8ECCBD4-20D6-4BB3-901A-7141724DBB59

P932

Q41012046-618C42DE-18B9-4086-94B2-B73CDE161115

P356

0974-9233.92116

P1433

Middle East African Journal of Ophthalmology

P1476

Diabetic retinopathy and inflammation: novel therapeutic targets

@en

P2093

Arup Das

http://www.w3.org/2001/XMLSchema#string

Paul G McGuire

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

Global estimates of the prevalence of diabetes for 2010 and 2030

The pathobiology of diabetic complications: a unifying mechanism

Matrix metalloproteinases: regulators of the tumor microenvironment

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

P304

52-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-9233.92116

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Sampathkumar Rangasamy

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22346115

http://www.w3.org/2001/XMLSchema#string

P932

3277025

http://www.w3.org/2001/XMLSchema#string